Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; macrogol 3350, quantity: 13.125 g - solution, powder for - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of chronic constipation. molaxole is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of the abdomen and rectum.

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - sodium sulfate, quantity: 7.5 g; macrogol 3350, quantity: 100 g; potassium chloride, quantity: 1.015 g; ascorbic acid, quantity: 4.7 g; sodium ascorbate, quantity: 5.9 g; sodium chloride, quantity: 2.691 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

specialised therapeutics glio pty ltd - aminolevulinic acid hydrochloride, quantity: 1.5 g - oral liquid, powder for - excipient ingredients: - gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant gliomas that are glioblastoma multiforme (gbm) on preoperative imaging, and who are intended for resection of the tumour.

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - ascorbic acid, quantity: 4.7 g; sodium chloride, quantity: 2.691 g; sodium sulfate, quantity: 7.5 g; potassium chloride, quantity: 1.015 g; macrogol 3350, quantity: 100 g; sodium ascorbate, quantity: 5.9 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - valganciclovir, quantity: 5 g - solution, powder for - excipient ingredients: mannitol; fumaric acid; sodium benzoate; saccharin sodium; povidone; flavour - valcyte is indicated for the treatment of cytomegalovirus (cmv) retinitis in adult patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prophylaxis of cmv disease in adult and paediatric solid organ transplantation (sot) patients who are at risk.

Ireland - English - HPRA (Health Products Regulatory Authority)

elanco gmbh - sodium chloride; glycine; potassium dihydrogen phosphate; sodium acid citrate; potassium citrate; sodium citrate; glucose monohydrate - powder for oral solution - . - oral electrolytes and carbohydrates

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sodium chloride ; potassium chloride; glucose; disodium hydrogen citrate - powder for oral solution - 0.47/0.30/3.56/0.53 gram(s) - oral rehydration salt formulations

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sodium chloride ; potassium chloride; glucose; disodium hydrogen citrate - powder for oral solution - 0.47/0.30/3.56/0.53 gram(s) - oral rehydration salt formulations

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sodium chloride ; potassium chloride; glucose; disodium hydrogen citrate - powder for oral solution - 0.47/0.30/3.56/0.53 gram(s) - oral rehydration salt formulations

Ireland - English - HPRA (Health Products Regulatory Authority)

opella healthcare france sas t/a sanofi - sodium chloride; potassium chloride; glucose; disodium hydrogen citrate - powder for oral solution - 3.56g/0.47g/0.53g/0.30 gram(s) - oral rehydration salt formulations